MNKD (MannKind) Ending Cash Position: $53.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MNKD MannKind Corp MNKD
66 GF Score
Price $4.18
GF Value $7.40
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MannKind Ending Cash Position?

MannKind MNKD -5.01% 66 Ending Cash Position is $53.7 Mil as of Jun. 2026. GuruFocus rates MNKD with a GF Score™ of 66/100 and a GF Value™ of $7.40 (Possible Value Trap). The stock has 8 warning signs investors should review.

MannKind's Ending Cash Position for the quarter that ended in Jun. 2026 was $53.7 Mil.

MannKind's quarterly Ending Cash Position declined from Dec. 2025 ($75.6 Mil) to Mar. 2026 ($53.6 Mil) but then increased from Mar. 2026 ($53.6 Mil) to Jun. 2026 ($53.7 Mil).

MannKind's annual Ending Cash Position declined from Dec. 2023 ($238.5 Mil) to Dec. 2024 ($47.1 Mil) but then increased from Dec. 2024 ($47.1 Mil) to Dec. 2025 ($75.6 Mil).

MannKind Ending Cash Position Related Terms

MannKind Ending Cash Position Historical Data

* Premium members only.

The historical data trend for MannKind's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MannKind Ending Cash Position Chart

MannKind Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.18 69.77 238.48 47.08 75.63

MannKind Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.75 128.14 75.63 53.58 53.68
MNKD
66GF Score
MannKind Corp MNKD
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MannKind Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MannKind's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=47.076+28.551
=75.6

MannKind's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=53.581+0.097000000000001
=53.7

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $53.7 Mil mean?
MannKind (MNKD) has a Ending Cash Position of $53.7 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MannKind and its competitors.
Is MannKind's Ending Cash Position too high?
MannKind's current Ending Cash Position is $53.7 Mil. Overall, MannKind has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MannKind's Ending Cash Position compare to ABSI and ORIC?
MannKind's Ending Cash Position of $53.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MannKind and its competitors. MannKind's current Ending Cash Position is $53.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MannKind stock overvalued right now?
Based on GuruFocus' analysis, MannKind (MNKD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.40, compared to a current price of $4.18 — trading 43.6% below its estimated fair value. The current Ending Cash Position is $53.7 Mil. MannKind's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For MannKind (MNKD), the current Ending Cash Position is $53.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MannKind (MNKD) Overvalued in 2026?

Based on GuruFocus' analysis, MannKind stock appears to be undervalued. The current stock price of $4.18 is trading 43.6% below its estimated GF Value™ of $7.40. GuruFocus considers MannKind to be Possible Value Trap.

Key valuation signals for MNKD:

  • Ending Cash Position: $53.7 Mil
  • GF Value™: $7.40 vs. price of $4.18 (43.6% below fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the MNKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MannKind Business Description

Other Exchanges NNFN:Germany
Address 1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
66GF Score

Get the complete analysis for MNKD

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.18
Price
$7.40
GF Value